Boston Scientific gains FDA’s OK for new PFA catheter

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
Medical Device Network

JPM26: Boston Scientific expects strong PFA performance for 2026 and beyond

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.
Stockhead on MSN

Scott Power: ASX healthcare stocks lift as sentiment improves

Morgans Scott Power positive of renewed momentum in the healthcare sector, which has risen 0.7% in the week ending January 16 ...

Ventricular Tachycardia Market to Hit $22.28 Billion by 2032, at a CAGR of 5.3%, says Coherent Market Insights

The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...